These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37025865)

  • 1. Lipidome, central carbon metabolites, and sleep rhythm in coronary heart disease with nontraditional risks: An exploratory pilot study.
    Xia Y; Chen A; Lu D; Jin J; Yin M; Wang Y; Zhang Y; Lu Y; Ma J; Deng L; Zhang P; Li S; Yang H; Li C; Lu H; Chen Z; Qian J; Ge J
    Heliyon; 2023 Apr; 9(4):e14827. PubMed ID: 37025865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Habitual sleep quality, plasma metabolites and risk of coronary heart disease in post-menopausal women.
    Huang T; Zeleznik OA; Poole EM; Clish CB; Deik AA; Scott JM; Vetter C; Schernhammer ES; Brunner R; Hale L; Manson JE; Hu FB; Redline S; Tworoger SS; Rexrode KM
    Int J Epidemiol; 2019 Aug; 48(4):1262-1274. PubMed ID: 30371783
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Yi M; Dai X; Li Q; Zhao Y; Nie S; Wang D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):591-600. PubMed ID: 34275927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.
    Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J
    Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered amino acid metabolism between coronary heart disease patients with and without type 2 diabetes by quantitative
    Zhang L; Zhang Y; Ma Z; Zhu Y; Chen Z
    J Pharm Biomed Anal; 2021 Nov; 206():114381. PubMed ID: 34583124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
    Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
    JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of plasma metabolites and comorbid illnesses with poor sleep quality in patients with coronary heart disease.
    Gökçe E; Arslan S; İşler A
    Sleep Breath; 2023 Dec; 27(6):2249-2255. PubMed ID: 37103681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features.
    Pabst T; Kortz L; Fiedler GM; Ceglarek U; Idle JR; Beyoğlu D
    BBA Clin; 2017 Jun; 7():105-114. PubMed ID: 28331812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: A case-cohort study.
    Razquin C; Liang L; Toledo E; Clish CB; Ruiz-Canela M; Zheng Y; Wang DD; Corella D; Castaner O; Ros E; Aros F; Gomez-Gracia E; Fiol M; Santos-Lozano JM; Guasch-Ferre M; Serra-Majem L; Sala-Vila A; Buil-Cosiales P; Bullo M; Fito M; Portoles O; Estruch R; Salas-Salvado J; Hu FB; Martinez-Gonzalez MA
    Int J Cardiol; 2018 Feb; 253():126-132. PubMed ID: 29306452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Metabolomic Profiles Between Black and White Women and Risk of Coronary Heart Disease: an Observational Study of Women From Four US Cohorts.
    Hu J; Yao J; Deng S; Balasubramanian R; Jiménez MC; Li J; Guo X; Cruz DE; Gao Y; Huang T; Zeleznik OA; Ngo D; Liu S; Rosal MC; Nassir R; Paynter NP; Albert CM; Tracy RP; Durda P; Liu Y; Taylor KD; Johnson WC; Sun Q; Rimm EB; Eliassen AH; Rich SS; Rotter JI; Gerszten RE; Clish CB; Rexrode KM
    Circ Res; 2022 Sep; 131(7):601-615. PubMed ID: 36052690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
    Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Fatty Acid Compositions of HDL Phospholipids Are Characteristic of Metabolic Syndrome and Premature Coronary Heart Disease-Family Study.
    Paavola T; Bergmann U; Kuusisto S; Kakko S; Savolainen MJ; Salonurmi T
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats.
    Zhao Y; Nie S; Yi M; Wu N; Wang W; Zhang Z; Yao Y; Wang D
    J Ethnopharmacol; 2019 Sep; 241():111908. PubMed ID: 31029757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lipid metabolite lipidomics assay for prediction and severity evaluation of rotator cuff injury.
    Huang H; Jiesisibieke D; Zhou X; Zhang Z; Duan X; Cheng X; Shao Z; Wang J; Zhang X
    Front Nutr; 2022; 9():1000947. PubMed ID: 36211515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and analysis on plasma metabolomics in patient with coronary heart disease of Xin-blood stasis syndrome pattern].
    Jian WX; Yuan ZK; Huang XP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):579-84. PubMed ID: 20815270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of Serum Metabonomics and Formula-Pattern Correspondence in Coronary Heart Disease Patients Diagnosed as Phlegm or Blood Stasis Pattern Based on Ultra Performance Liquid Chromatography Mass Spectrometry.
    Lu XY; Xu H; Zhao T; Li G
    Chin J Integr Med; 2018 Dec; 24(12):905-911. PubMed ID: 29948595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study.
    Cruz DE; Tahir UA; Hu J; Ngo D; Chen ZZ; Robbins JM; Katz D; Balasubramanian R; Peterson B; Deng S; Benson MD; Shi X; Dailey L; Gao Y; Correa A; Wang TJ; Clish CB; Rexrode KM; Wilson JG; Gerszten RE
    JAMA Cardiol; 2022 Feb; 7(2):184-194. PubMed ID: 34851361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
    Gu Y; Zang P; Li J; Yan Y; Wang J
    Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone.
    Xu B; Chen Y; Chen X; Gan L; Zhang Y; Feng J; Yu L
    Front Oncol; 2021; 11():730638. PubMed ID: 34722271
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.